(Q1686818)
Statements
1 reference
8 September 2024
Subsidiaries andaffiliated companiesof Bayer AG and the Bayer Group as ofDecember 31, 2023, pursuant to Section 285,No. 11, 11a and 11b, and Section 313 of theGerman Commercial Code (English)
41,100,000 Euro
31 December 2023
1 reference
8 September 2024
Subsidiaries andaffiliated companiesof Bayer AG and the Bayer Group as ofDecember 31, 2023, pursuant to Section 285,No. 11, 11a and 11b, and Section 313 of theGerman Commercial Code (English)
20,100,000 Euro
2023
1 reference
8 September 2024
Subsidiaries andaffiliated companiesof Bayer AG and the Bayer Group as ofDecember 31, 2023, pursuant to Section 285,No. 11, 11a and 11b, and Section 313 of theGerman Commercial Code (English)
1 reference
8 September 2024
Subsidiaries andaffiliated companiesof Bayer AG and the Bayer Group as ofDecember 31, 2023, pursuant to Section 285,No. 11, 11a and 11b, and Section 313 of theGerman Commercial Code (English)
Jenapharm
0 references
Identifiers
Sitelinks
Wikipedia(6 entries)
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(1 entry)
- commonswiki Category:Jenapharm